1. Home
  2. TRDA vs TASK Comparison

TRDA vs TASK Comparison

Compare TRDA & TASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$12.65

Market Cap

500.4M

Sector

Health Care

ML Signal

HOLD

Logo TaskUs Inc.

TASK

TaskUs Inc.

HOLD

Current Price

$6.54

Market Cap

585.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRDA
TASK
Founded
2016
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
500.4M
585.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
TRDA
TASK
Price
$12.65
$6.54
Analyst Decision
Strong Buy
Hold
Analyst Count
3
5
Target Price
$21.00
$14.70
AVG Volume (30 Days)
144.6K
571.1K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
120.00
EPS
N/A
1.10
Revenue
$25,421,000.00
N/A
Revenue This Year
$39.97
$5.95
Revenue Next Year
$50.80
$6.46
P/E Ratio
N/A
$5.90
Revenue Growth
N/A
N/A
52 Week Low
$4.93
$6.20
52 Week High
$14.49
$18.39

Technical Indicators

Market Signals
Indicator
TRDA
TASK
Relative Strength Index (RSI) 46.56 34.71
Support Level $10.84 $6.30
Resistance Level $12.93 $7.54
Average True Range (ATR) 0.58 0.33
MACD -0.19 0.09
Stochastic Oscillator 23.92 22.66

Price Performance

Historical Comparison
TRDA
TASK

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About TASK TaskUs Inc.

TaskUs Inc provides outsourced digital services. Its service offerings include Digital Customer Experience consists of omnichannel customer care services, delivered through digital (non-voice) channels, also including learning experience and sales and customer acquisition services; Trust & Safety consists of monitoring, reviewing and managing user and advertiser-generated content on online platforms to ensure it complies with community guidelines, legal regulations and platform specific policies; and AI Services consists of large language model support and high-quality data labeling services, annotation, context relevance and transcription services performed for the purpose of training and tuning machine learning algorithms, enabling them to develop cutting-edge AI systems.

Share on Social Networks: